Neumora Therapeutics, Inc.NMRA

1 13D/G filings 1 distinct filers 0 insider transactions (365d)

Cross-Reference Snapshot

Activist filings

1 SCHEDULE 13D/A

Distinct filers

single filer

Insiders (365d)

0 buys · 0 sales

Latest short DTC

4.03

as of 2026-03-31

Held by elite portfolio managers

1 holder · $6.58M

Point72 Asset Mgmt

Filed	Form	Filer	Stake	Shares	Intent
2026-04-01	SCHEDULE 13D/A	ARCH Venture Fund XII, L.P.	18.70%	33,847,838		view →

Settlement	Short Interest	Days to Cover	% Δ vs prior
2026-03-31	4,326,409	4.03	-12.8%
2026-03-13	4,958,521	4.91	-5.0%
2026-02-27	5,216,610	5.99	-13.7%
2026-02-13	6,045,735	2.57	+7.3%
2026-01-30	5,634,962	6.36	-5.9%
2026-01-15	5,986,621	1.55	-20.2%
2025-12-31	7,502,647	8.35	+7.5%
2025-12-15	6,982,708	7.16	+7.9%

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts · full feed · daily intelligence · API. $1,500/mo. Pilots welcome.